These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 17940530)

  • 1. Network-based classification of breast cancer metastasis.
    Chuang HY; Lee E; Liu YT; Lee D; Ideker T
    Mol Syst Biol; 2007; 3():140. PubMed ID: 17940530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
    Khunlertgit N; Yoon BJ
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Steiner tree-based method for biomarker discovery and classification in breast cancer metastasis.
    Jahid MJ; Ruan J
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S8. PubMed ID: 23134806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying cancer biomarkers by network-constrained support vector machines.
    Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
    BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of diagnostic subnetwork markers for cancer in human protein-protein interaction network.
    Su J; Yoon BJ; Dougherty ER
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S8. PubMed ID: 20946619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network motif-based identification of breast cancer susceptibility genes.
    Zhang Y; Xuan J; de Los Reyes BG; Clarke R; Ressom HW
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5696-9. PubMed ID: 19164010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
    Zheng T; Wang A; Hu D; Wang Y
    Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed genes associated with the metastatic phenotype in breast cancer.
    Kirschmann DA; Seftor EA; Nieva DR; Mariano EA; Hendrix MJ
    Breast Cancer Res Treat; 1999 May; 55(2):127-36. PubMed ID: 10481940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
    Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
    BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers.
    Bell R; Barraclough R; Vasieva O
    Curr Mol Med; 2017; 17(3):200-210. PubMed ID: 28782484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased entropy of signal transduction in the cancer metastasis phenotype.
    Teschendorff AE; Severini S
    BMC Syst Biol; 2010 Jul; 4():104. PubMed ID: 20673354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
    Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
    Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells.
    Hermawan A; Putri H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular markers for metastasis-related genes in primary breast cancer cells.
    Mimori K; Kataoka A; Yoshinaga K; Ohta M; Sagara Y; Yoshikawa Y; Ohno S; Barnard GF; Mori M
    Clin Exp Metastasis; 2005; 22(1):59-67. PubMed ID: 16132579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.